Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Natera Introduces ABCSG 61’s TEODOR Trial Announcement Natera Inc., a well-known leader in cell-free DNA and precision medicine, has begun a new TEODOR trial, a neoadjuvant treatment optim...
Four Biotech Companies Standing Strong Against Market Waves A Drug Struggles Through Clinical Trials A drug typically takes around 10 to 15 years to undergo clinical trials, and after completing...
Benecard and DecisionRX Formed a Partnership to Enhance Pharmacy Benefits Announcement DecisionRX, Inc., a key player in medication therapy optimization (MTO), and Benecard PBF, the original pha...
Kedrion’s COAGADEX® Received Confirmation of ‘Orphan Drug Designation' Announcement Kedrion Biopharma’s COAGADEX is now declared an orphan drug designation from the US Food...
Genethon's New Trial in Europe for Duchenne Muscular Dystrophy Announcement Genethon, a global prominent leader in research and development in gene therapy for rare genetic diseases, received ap...
Bristol and Bain Capital’s New Company Announcement Bristol-Myers Squibb and Bain Capital together have built a new independent biopharmaceutical company. A company that will be aiming the...
Pahr Therapeutics Raises Funds to Contribute to Pulmonary Arterial Hypertension Announcement Pahr Therapeutics Inc. was financed with $14M, along with AN Venture partners, University of Tokyo Ed...
Virocell and Avencell Partnered to Elevate Development in Treatments Announcement Virocell biologics, a popular vector contract development and manufacturing organization (CDMO) for cell and gen...
Spear Bio’s New Solution to Modify Neurodegenerative Disease Research Announcement Spear Bio, a leading biotechnology company evolving homogeneous ultrasensitive immunoassay technology, ha...
The Rising Alzheimer's Disease has Led Biopharma to Enter a Holistic Treatment Era The start to look up for In the last two years, 2023 and 2024, the treatment for the first-ever disease, Alzhei...
Speak with a healthcare analyst about your research, consulting, or platform needs.